Skip to content
Biodatica
Start free

Investigator

Neville Sanjana

NEW YORK GENOME CENTER · funded by NHGRI, NCI

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.7M

Summed across those awards.

First award
Apr 10, 2023

Latest Sep 15, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Multiscale genome engineering to map cis-regulatory variants in human and mouse

    $1.1M

    Sep 15, 2023NHGRINEW YORK GENOME CENTERNIH RePORTER · 11135344 (opens the source filing in a new tab)

  2. R01

    LTBR CARs as next-generation therapies for R/R lymphoma

    $810k

    Apr 10, 2023NCINEW YORK GENOME CENTERNIH RePORTER · 11045028 (opens the source filing in a new tab)

  3. R01

    LTBR CARs as next-generation therapies for R/R lymphoma

    $819k

    Apr 10, 2023NCINEW YORK GENOME CENTERNIH RePORTER · 11311797 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources